Merck’s Covid-19 pill close to regulator nod in India, may cost Rs 500-Rs 1,000
Express News Service NEW DELHI: The oral Covid-19 pill developed by US drug major Merck and Ridgeback Biotherapeutics could be…
Express News Service NEW DELHI: The oral Covid-19 pill developed by US drug major Merck and Ridgeback Biotherapeutics could be…